New hope for diabetic foot ulcers: cell therapy tested in phase 3 trial
Disease control
Completed
This study tested a treatment called ALLO-ASC-DFU for diabetic foot ulcers that are deep but not infected. It included 104 adults with type 1 or type 2 diabetes. The goal was to see if the treatment helps wounds close completely compared to a placebo.
Phase: PHASE3 • Sponsor: Anterogen Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC